Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.
Posted 28 June 2013 | By Ansis Helmanis,
The Australia New Zealand Therapeutic Products Agency (ANZTPA) has launched an adverse event reporting database, the Joint Adverse Event Notifications System (JAENS), that combines drug and device adverse event reports received by Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medicines and Medical Devices Safety Authority (Medsafe).
Reports come from a wide range of sources, including members of the public, general practitioners, nurses, other health professionals and the therapeutic products industry. JAENS includes two search functions, one for specifically for drugs, and the other for devices
Since June 2011, Australia and New Zealand have been moving towards a joint regulatory scheme for therapeutic products. The two countries anticipate that ANZTPA will replace the TGA and Medsafe in 2016.
JAENS Announcement
Read all Breaking News from RegLink
Tags: New Zealand, australia